Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Stroke is a leading cause of death and disability worldwide.Hemiplegia, weakness of one side of the body, is a common consequence of stroke that can lead to significant functional impairments. Loss of arm function occurs in up to 85% of stroke survivors. The impact of arm-related limitations on activities of daily living, leisure activities or work is significant as the arm plays a central role in a person's life from the ability to perform basic activities of daily life to carrying out family and social roles. Guidelines indicate that rehabilitation can improve upper extremity (UE) motor control and functional status post stroke. Virtual reality (VR) and computer games are recent technologies that, as they become more accessible and affordable,are increasingly being used in rehabilitation to allow patients to engage in repetitive practice of specific tasks. A number of published reviews and meta-analyses have examined the use of VR and video games for post-stroke rehabilitation, focusing on or including UE rehabilitation. The authors agree that there is limited but promising findings that VR and video-games, when combined with traditional rehabilitation, have a positive impact on recovery post-stroke.
The goal of the study is to assess the feasibility, safety, and acceptability of the Jintronix system, as well as provide preliminary evidence regarding the clinical efficacy for post-stroke rehabilitation.This is a pilot parallel randomised single-blinded controlled trial, with patients who have had a stroke randomly allocated to one of two groups: (1) usual rehabilitation services and additional training with Jintronix system (treatment group) or (2) usual rehabilitation services only (control group).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention arm, usual rehabilitation + Jintronix exergame | Experimental | On top of the usual out-patient rehabilitation sessions planned for the participant, participants attend sessions to use the Jintronix system for up 30 minutes up to 3 times per week |
|
| Control group | Other | Participants continue their prescribed rehabilitation sessions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exergame | Other | Participants use exergame with the therapist in the rehabilitation center. Several games are available, the therapist adjusts the choice of game and level of difficulty according to the participant's abilities and interests. |
| Measure | Description | Time Frame |
|---|---|---|
| number of sessions (feasibility) | number of sessions the participant used the system during the study period | 4 week period |
| duration of sessions | the average duration of sessions (minutes) | 4 week period (ongoing) |
| time spent by therapist assisting the participant | time during the sessions that the therapist spent assisting the participant (minutes) | 4 week period (ongoing) |
| time spent on each exergame | the time spent on each exergame (minutes) | 4 week period (ongoing) |
| adverse event (counts) | occurrence of adverse events such as falls, motion sickness, dizziness and headaches | 4 week period (ongoing) |
| adverse event (borg exertion scale, self-reported scale 6-20, (Borg Exertion Scale scored from 6-20, no exertion to maximal exertion) | exertion after playing the exergame reported using the Borg Exertion Scale | 4 week period (ongoing) |
| adverse event (pain self reported on visual analog scale 0-10) | pain after playing the exergame reported using visual analog scale 0-10, 0 is no pain, 10 is the worse pain imaginable. | 4 week period (ongoing) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Université de Montréal | Montreal | Quebec | H3N 1X7 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000088544 | Exergaming |
| ID | Term |
|---|---|
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| usual care | Other | participants continued their planned rehabilitation sessions |
|
| Stroke-specific measure of quality of life - Stroke Impact Scale |
Stroke Impact Scale is a questionnaire of the impact that the stroke is having on function, mood, emotional status, total score 0-100, with with higher scores indicating better self-reported health. |
| 4 week period (per-post) |
| upper limb function assessed using the Motor Activity Log | The Motor Activity Log is a questionnaire that the participant completes reporting how much the impaired upper limb is used for various daily tasks, each task is scored from 0-5 (ordinal scale, 0=do not use arm - 6=use as much as before), total score is mean of the scores. | 4 week period (per-post) |
| upper limb function assessed using the Box and Block test | upper limb function is assessed using the box and block test where participants are timed while picking up and placing wooden cubes | 4 week period (per-post) |
| upper limb motor control assessed using the Fugl-Meyer Assessment-upper extremity | Upper limb motor control is assessed using a valid and reliable outcome, measure consisting of tasks to be performed by the participant, scores between 0-66, higher scores indicating better motor control. | 4 week period (per-post) |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D055687 |
| Musculoskeletal and Neural Physiological Phenomena |